Studying the Effect of Pharmaceutical Nanoparticles on Targeting Inflamed Tissues: A Pharmacokinetic and Dynamic Analysis

Khetam Abdalsada Ali Alhilali Alhilali

doi:10.51699/cajmns.v6i4.2956

Authors

Khetam Abdalsada Ali Alhilali Alhilali University of Al Qadisiysh, College of Dentistry, Iraq

DOI:

https://doi.org/10.51699/cajmns.v6i4.2956

Keywords:

delivery technologies, Pharmaceutical Nanoparticles, Diseases

Abstract

This review seeks to mechanistically analyze the effects of medicinal nanoparticles on specific infected tissues, including comprehensive pharmacokinetic and pharmacodynamic assessments. Nanoparticle technology is one of the new trends in drug delivery that has shown promise for improving targeted medication transport to educational settings, even if it doesn't work as well as planned dosages and side effects from standard dosage forms. These have focused on medication delivery systems based on nanoparticles—passive targeting via the inherent features of malignant tissues and active targeting by modifying the surface area of nanoparticles with particular antibodies or particles.The research is based on gold standard animal models exhibiting inflammatory disorders such as rheumatoid arthritis and inflammatory bowel diseases, since they are rigorously examined using conventional methodologies to assess the efficacy of drug-loaded nanoparticles in inflammatory states. In fact, pharmacokinetic analysis is used to keep track of where the nanoparticles go and how they move about in the body. On the other hand, pharmacodynamic studies look at how drug-loaded nanoparticles can help reduce inflammation and improve treatment at the site of delivery.Results are anticipated to provide significant insights into the processes facilitating the inflammatory niche-specific localization of nanoparticles to diseased tissue, hence allowing targeted intervention in inflamed tissue with enhanced safety and a possibly expanded therapeutic window. This narrative review examines the use of nanotechnology in clinical endeavors, providing a scientific foundation for the improvement of existing therapeutic strategies for chronic inflammatory diseases. Real-Life Uses: This discovery is bringing us closer to huge new areas of nanomedicine and drug delivery technologies.

References

W. Ulbrich, A. Lamprecht, "Targeted drug-delivery approaches by nanoparticulate carriers in the therapy of inflammatory diseases," J. R. Soc. Interface, vol. 7, pp. S55-S66, 2010.

G. Storm, et al., "Nanoparticles in cancer therapy and diagnosis," Adv. Drug Deliv. Rev., vol. 54, no. 6, pp. 631-651, 2002.

P. Couvreur, I. Brigger, "Nanoparticles in cancer therapy," Advanced Drug Delivery Reviews, vol. 54, pp. 631-651, 2002.

S. Gupta, D. Shukla, P. N. Sharma, et al., "Fluorescent nanoparticles for drug delivery applications," Biomaterials, vol. 31, no. 6, pp. 1183-1193, 2010.

L. Moghimi, M. J. Simberg, R. M. Swanson, et al., "Pharmacokinetics of nanoparticle-based drug delivery systems," Journal of Nanomedicine, vol. 3, no. 6, pp. 198-206, 2007.

A. S. Zhang, et al., "Therapeutic applications of nanoparticle-based drug delivery systems in inflammatory diseases," J. Nanomedicine, vol. 12, no. 4, pp. 185-198, 2016.

J. L. Stone, J. D. R. Jones, "Pharmacokinetics of drug delivery systems: A review of techniques," Pharmacological Reports, vol. 68, pp. 423-429, 2016.

R. M. Gupta, M. C. Smith, "Nanoparticle distribution and interaction in biological systems: Electron microscopy analysis," Advanced Materials Science, vol. 45, no. 2, pp. 221-230, 2015.

L. H. Yang, et al., "Polymer-based nanoparticles for controlled drug delivery: Synthesis, characterization, and therapeutic applications," J. Control Release, vol. 157, pp. 272-288, 2014.

H. K. Nguyen, P. J. Williams, "Immunohistochemical analysis of nanoparticle distribution in tissues," Histology and Cell Biology, vol. 65, no. 1, pp. 49-56, 2017.

M. C. Allen, "Nanoparticle drug delivery systems: Principles, mechanisms, and applications," J. Nanomedicine, vol. 7, no. 1, pp. 1-14, 2018.

R. M. Gupta, A. B. Choudhury, "Targeted drug delivery: From nanoparticles to tissues," Int. J. Pharm. Technol., vol. 8, no. 4, pp. 113-120, 2019.

L. K. Brown, J. P. Turner, "Pharmacokinetics of nanoparticle-based drugs," Pharmaceutical Research, vol. 32, pp. 2851-2864, 2015.

H. R. Das, A. R. Smith, "Safety and efficacy of nanoparticle systems in drug delivery," Journal of Controlled Release, vol. 221, pp. 130-145, 2017.

M. E. Davis, Z. G. Chen, D. M. Shin, "Nanoparticle therapeutics: An emerging treatment modality for cancer," Nat. Rev. Drug Discov., vol. 7, no. 9, pp. 771-782, 2008.